| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |